A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC)

被引：0
|
作者：
Evans, T. R. Jeffry
Eatock, Martin McKinlay
Lewsley, Liz-Anne
Kelly, Caroline
McCartney, Elaine
Duffton, Aileen
Houston, Peter
Harrison, Claire
Purcell, Colin
Ashton, Miranda
Morton, Alanna
Graham, Jill
Chalmers, Anthony J.
Thomson, Fiona
Pou, Chantevy
Bilsland, Alan
Cooke, Susie
McIntosh, David
Grose, Derek B.
机构：
[1] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[2] Belfast City Hosp, Belfast, Antrim, North Ireland
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland
[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[6] N Ireland Canc Ctr, Belfast, Antrim, North Ireland
[7] Northern Ireland Canc Ctr, Belfast, Antrim, North Ireland
[8] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
709
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
    C N Hurt
    S Falk
    T Crosby
    A McDonald
    R Ray
    G Joseph
    J Staffurth
    R A Abrams
    G Griffiths
    T Maughan
    S Mukherjee
    British Journal of Cancer, 2017, 116 : 1264 - 1270
  • [32] Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
    Hurt, C. N.
    Falk, S.
    Crosby, T.
    McDonald, A.
    Ray, R.
    Joseph, G.
    Staffurth, J.
    Abrams, R. A.
    Griffiths, G.
    Maughan, T.
    Mukherjee, S.
    BRITISH JOURNAL OF CANCER, 2017, 116 (10) : 1264 - 1270
  • [33] Gemcitabine (G) plus nab-paclitaxel (nab-P) plus chemoradiation (CRT) in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga Olanrele
    Bedoya, Ivan Dario
    Mierzwa, Michelle Lynn
    Torregroza, Maria Patricia
    Dwivedi, Alok Kumar
    Wang, Jiang
    Smith, Milton T.
    Schmulewitz, Nathan
    Kucera, Stephen
    Choe, Kyuran Ann
    Ristagno, Ross
    Rudich, Steven
    Sussman, Jeffrey J.
    Ahmad, Syed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Preoperative capecitabine (X) chemoradiation is effective and well tolerated in patients (PTS) with locally advanced rectal cancer (LARC): findings from a phase I dose escalation study
    Veerasarn, V
    Phromratanapongse, P
    Lorvidhaya, V
    Lertsanguansinchai, P
    Panichchevaluk, A
    Boonnuch, W
    Chinswangwatanakul, V
    Lahsiriwat, D
    Rojanasakul, A
    Thavichaigarn, P
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S267 - S267
  • [35] Phase I trial of capecitabine and gemcitabine with radiotherapy in locally advanced pancreatic cancer
    Leong, T.
    Michael, M.
    Price, T.
    Ganju, V
    Strickland, A.
    Jefford, M.
    Muller, A.
    Ngan, S.
    Milner, A.
    Zalcberg, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
  • [36] Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer - A phase I study
    Iannitti, D
    Dipetrillo, T
    Akerman, P
    Barnett, JM
    Maia-Acuna, C
    Cruff, D
    Miner, T
    Martel, D
    Cioffi, W
    Remis, M
    Kennedy, T
    Safran, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 570 - 575
  • [37] Phase 1 Study of Preoperative Chemoradiation Therapy With Temozolomide and Capecitabine in Patients With Locally Advanced Rectal Cancer
    Jeong, Jae Ho
    Hong, Yong Sang
    Park, Yangsoon
    Kim, Jihun
    Kim, Jeong Eun
    Kim, Kyu-pyo
    Kim, Sun Young
    Park, Jin-hong
    Kim, Jong Hoon
    Park, In Ja
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Jin Cheon
    Kim, Tae Won
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : 289 - 295
  • [38] Phase I trial of gene-mediated cytotoxic immunotherapy in combination with chemoradiation for locally advanced pancreatic cancer
    Bloomston, M.
    Marsh, C.
    Walker, J.
    Coyle, W.
    Marx, H.
    Tahiri, S.
    Cruz, C. Moran
    Aguilar, L. K.
    Aguilar-Cordova, E.
    Chung, V. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [39] A phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Tang, P.
    Oza, A.
    Townsley, C.
    Siu, L.
    Pond, G.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J.
    Chen, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Phase I trial of chemoradiation with capecitabine and vorinostat in pancreatic cancer
    Chan, E.
    Arlinghaus, L. R.
    Cardin, D. B.
    Goff, L.
    Berlin, J.
    Parikh, A.
    Abramson, R. G.
    Merchant, N.
    Hiebert, S.
    Chakravarthy, A. B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S584 - S584
12345